Chemiluminescence Immunoassay (CLIA) Analyzers Market (By Product: Analyzers, Reagents, Consumables; By Application: Endocrine Disorder, Oncology, Infectious Diseases, Hepatitis and Retrovirus, Cardiovascular Disorders, Allergy, Autoimmunity, Drug Discovery & Development, Others; By End-user: Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Industries, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20212030

According to Vision Research Reports, the global chemiluminescence immunoassay (CLIA) analyzers market size surpassed at US$ 10.2 Bn in 2020 and is projected to expand at a CAGR of 10.4% from 2020 to 2030.

The global chemiluminescence immunoassay (CLIA) analyzers market size is expected to reach US$ 16.60 billion by 2030, high incidence & prevalence of chronic diseases to escalate the growth of global chemiluminescence immunoassay (CLIA) analyzers market. Moreover, increase in demand for laboratory automation is boost the growth of market.

Overview

• Chemiluminescence immunoassay (CLIA) is an assay that combine chemiluminescence technique with immunochemical reactions. Chemiluminescence immunoassay analyzers comprise products such analyzers, reagents, and consumables. Diagnostic technology is rapidly evolving, and over the last decade, and increasingly approach of automated clinical diagnostics laboratory leads to drive the growth of market
• The world is currently experiencing the pandemic of an infectious disease called COVID-19. This is leading to increase in demand for the point of care tests and central laboratory tests helps in the development of varied tools including chemiluminescence immunoassay analyzers
• The chemiluminescence immunoassay (CLIA) analyzers market is currently a booming one, since there has been surge in demand for laboratory automation and consolidation to improve precision and efficiency. Factors such as large sample processing capacity, large parameters testing in short period of time, high throughput, minimum labor requirement, integrated quality control & data storage, and integrated quality control and validation facility with an objective to improve overall efficacy and precision of tests with reduced turnover and incubation times is likely to drive the market during the forecast period
• North America dominate the global chemiluminescence immunoassay (CLIA) analyzers market in 2018 and the trend is anticipated to continue during the forecast period. Significant average selling prices of automated chemiluminescence immunoassay analyzers, rising demand from surgeons for technologically advanced diagnostic instruments with enhanced specificity and precision, and favorable coverage as per the Clinical Laboratory Improvement Amendments for in-vitro diagnostic procedures are the factors anticipated to drive the growth of market
• Asia Pacific is likely to be a highly lucrative market for the chemiluminescence immunoassay (CLIA) analyzers market and it is expected to expand at a high CAGR during the forecast period. Large population base and rise in incidence of chronic and infectious diseases boosts demand for diagnostic testing in the region. Moreover, government initiative to improve healthcare infrastructure is likely augment the market

Ultrasensitive Method with Dynamic Range of Tests to Drive Global Chemiluminescence Immunoassay (CLIA) Analyzers Market

• The CLIA technology provides enhanced sensitivity, specificity, improved precision, and reduced incubation, which together increases efficiency of this technique
• Additionally, CLIA analysis is offered at relatively lower price as compared to other ultra-sensitive methods such as flow cytometry. The method also incorporates precise results with lower variation and improved comparability with the standards used in the assays.
• Major manufacturers operating in the market are involved in continuous research & development activities to expand their already wide product portfolio. Thus, continuous expansion of test offering in high throughput systems along with reduced waiting time and improved results specificity are likely to drive the growth of global CLIA market during the forecast period

 Reagent Segment to Dominate Chemiluminescence Immunoassay (CLIA) Analyzers Market

• In terms of product, the global chemiluminescence immunoassay (CLIA) analyzers market has been segmented into analyzers, reagents and consumables. Analyzers segment further divided into fully automated and semi-automated. Reagents segment covers the luminophore markers and enzymatic markers. Reagents segment accounted for major share of the market. Increasing adoption of CLIA due to increasing advanced test offering is likely to drive the reagents segment during the forecast period. Moreover, lower cost and shorter test time are likely to propel the segment during the forecast period

Endocrine Disorder Segment Hold a Major Share of Global Chemiluminescence Immunoassay (CLIA) Analyzers Market

• In terms of application, the global chemiluminescence immunoassay (CLIA) analyzers market has been classified into endocrine disorders, oncology, infectious diseases, hepatitis and retrovirus, cardiovascular disorders, allergy, autoimmunity, drug discovery & development and others. Endocrine segment dominated the market in 2018 and it continue its dominance during the forecast period. Major factors responsible for the dominance of this segment are continuous innovations in test offerings and wide product portfolio of major as well as local manufacturers. A majority of new entrants are focused on this segment, as the overall procedure volume of this segment is relatively higher across all regions due to higher preference by physicians for endocrine testing using CLIA due to their higher specificity and availability of standardized tests

Hospitals Segment to Dominate Global Chemiluminescence Immunoassay (CLIA) Analyzers Market

• Based on end-user, the global chemiluminescence immunoassay (CLIA) analyzers market has been segmented into hospitals, clinical laboratories, pharmaceutical & biotechnology industries and others. Hospitals segment accounted for major share of the market. Increasing number of applications of automated CLIA analyzers in therapeutic drug monitoring, oncology, and companion diagnostics and introduction of integrated modules of automated CLIA analyzers are likely to drive the hospitals segment during the forecast period. The rising group purchase of test kits, increasing number of rental service contracts, and high commercialization aspect due to use of almost all application areas in tests are some of the major factors responsible for continued dominance of the hospital segment

North America to Dominate Global Chemiluminescence Immunoassay (CLIA) Analyzers Market

• In terms of region, the global chemiluminescence immunoassay (CLIA) analyzers market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global chemiluminescence immunoassay (CLIA) analyzers market in 2018, followed by Europe.
• North America accounted for major share of the global chemiluminescence immunoassay (CLIA) analyzers market in 2018. Gradual rise in the demand for multiplexing diagnostic tools and an increase in investment in the development of these tools are the factors contribute to drive the growth of market.
• The chemiluminescence immunoassay (CLIA) analyzers market in Asia Pacific is anticipated to expand at a high CAGR from 2020 to 2030. Change in dynamics of the in vitro diagnostics industry leads surge in adoption of new technologies among hospitals and diagnostic laboratories and thereby drive the growth of market

Competitive Landscape

• The global chemiluminescence immunoassay (CLIA) analyzers market is fragmented in terms of number of players. Key players in the global chemiluminescence immunoassay (CLIA) analyzers market include Abbott, F. Hoffmann-La Roche Ltd,  Siemens Healthineers (Siemens AG), Danaher (Beckman Coulter, Inc.), DiaSorin S.p.A, Ortho Clinical Diagnostics (Part of Carlyle Group), Shenzhen New Industries Biomedical Engineering Co., Ltd., Sysmex Corporation, Randox Laboratories Ltd. and Tosoh Corporation

Market Segmentation:

By Product

• Analyzers
• Fully automated
• Semi-automated
• Reagents
• Luminophore Markers
• Enzymatic Markers
• Consumables 

By Application

• Endocrine Disorders
• Oncology
• Infectious Diseases
• Hepatitis and Retrovirus
• Cardiovascular Disorders
• Allergy
• Autoimmunity
• Drug Discovery & Development
• Others 

By End-user

• Hospitals
• Clinical Laboratories
• Pharmaceutical & Biotechnology Industries
• Others

By Region

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia & New Zealand
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Scope of Report

VRRR’s report on the global chemiluminescence immunoassay (CLIA) analyzers market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2020 to 2030. The report provides revenue of the global chemiluminescence immunoassay (CLIA) analyzers market for the period 2016–2030, considering 2020 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global chemiluminescence immunoassay (CLIA) analyzers market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global chemiluminescence immunoassay (CLIA) analyzers market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global chemiluminescence immunoassay (CLIA) analyzers market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global chemiluminescence immunoassay (CLIA) analyzers market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global chemiluminescence immunoassay (CLIA) analyzers market.

The report delves into the competitive landscape of the global chemiluminescence immunoassay (CLIA) analyzers market. Key players operating in the global chemiluminescence immunoassay (CLIA) analyzers market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global chemiluminescence immunoassay (CLIA) analyzers market that have been profiled in this report

Key Questions Answered in Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Report

• What is the scope of growth for product companies in the global chemiluminescence immunoassay (CLIA) analyzers market?
• What will be the Y-o-Y growth of the global chemiluminescence immunoassay (CLIA) analyzers market between 2020 and 2030?
• What is the influence of changing trends in technologies on the global chemiluminescence immunoassay (CLIA) analyzers market?
• Will North America continue to be the most profitable market for chemiluminescence immunoassay (CLIA) analyzers providers?
• Which factors are anticipated to hamper the growth of the global chemiluminescence immunoassay (CLIA) analyzers market during the forecast period?
• Which are the leading companies in the global chemiluminescence immunoassay (CLIA) analyzers market?

Research Methodology

A unique research methodology has been utilized by VRR to conduct comprehensive research on the growth of the global chemiluminescence immunoassay (CLIA) analyser market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary research sources referred to by analysts during the production of the global chemiluminescence immunoassay (CLIA) analyzer market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of VRR’s study on the chemiluminescence immunoassay (CLIA) analyser market as primary methods.

These primary research respondents have provided exclusive information during interviews, which serves as a validation from the chemiluminescence immunoassay (CLIA) analyzer market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global chemiluminescence immunoassay (CLIA) analyser market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching VRR’s estimates on future prospects of the global chemiluminescence immunoassay (CLIA) analyser more reliably and accurately.